Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis
Marco Cosentino(University of Insubria), Franca Marino(University of Insubria), Laura Schembri(Royal Brompton Hospital), Raffaella Clerici(CTO Hospital), Paola Banfi, Massimiliano Legnaro(University of Insubria), Mario Guidotti(Ospedale Valduce), Anna Bianchi, Giorgio Bono(University of Insubria), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), R Bombelli(University of Insubria), Damiano Baroncini
Cited by 20
Related Papers
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Prospective study of multiple sclerosis with early onset
|Multiple Sclerosis Journal|2002|152